INTERNATIONAL STANDARDIZATION OF CRITERIA FOR THE HISTOLOGIC DIAGNOSIS OF RENAL-ALLOGRAFT REJECTION - THE BANFF WORKING CLASSIFICATION OF KIDNEY-TRANSPLANT PATHOLOGY

被引:1288
作者
SOLEZ, K
AXELSEN, RA
BENEDIKTSSON, H
BURDICK, JF
COHEN, AH
COLVIN, RB
CROKER, BP
DROZ, D
DUNNILL, MS
HALLORAN, PF
HAYRY, P
JENNETTE, JC
KEOWN, PA
MARCUSSEN, N
MIHATSCH, MJ
MOROZUMI, K
MYERS, BD
NAST, CC
OLSEN, S
RACUSEN, LC
RAMOS, EL
ROSEN, S
SACHS, DH
SALOMON, DR
SANFILIPPO, F
VERANI, R
VONWILLEBRAND, E
YAMAGUCHI, Y
机构
[1] Dept. of Lab. Medicine and Pathology, University of Alberta, 5B4.02 Walter Mackenzie Centre, Edmonton
关键词
D O I
10.1038/ki.1993.259
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
A group of renal pathologists, nephrologists, and transplant surgeons met in Banff, Canada on August 2-4, 1991 to develop a schema for international standardization of nomenclature and criteria for the histologic diagnosis of renal allograft rejection. Development continued after the meeting and the schema was validated by the circulation of sets of slides for scoring by participant pathologists. In this schema intimal arteritis and tubulitis are the principal lesions indicative of acute rejection. Glomerular, interstitial, tubular, and vascular lesions of acute rejection and ''chronic rejection'' are defined and scored 0 to 3+, to produce an acute and/or chronic numerical coding for each biopsy. Arteriolar hyalinosis (an indication of cyclosporine toxicity) is also scored. Principal diagnostic categories, which can be used with or without the quantitative coding, are: (1) normal, (2) hyperacute rejection, (3) borderline changes, (4) acute rejection (grade I to III), (5) chronic allograft nephropathy (''chronic rejection'') (grade I to III), and (6) other. The goal is to devise a schema in which a given biopsy grading would imply a prognosis for a therapeutic response or long-term function. While the clinical implications must be proven through further studies, the development of a standardized schema is a critical first step. This standardized classification should promote international uniformity in reporting of renal allograft pathology, facilitate the performance of multicenter trials of new therapies in renal transplantation, and ultimately lead to improvement in the management and care of renal transplant recipients.
引用
收藏
页码:411 / 422
页数:12
相关论文
共 53 条
[1]  
AXELSEN RA, 1985, CLIN NEPHROL, V23, P1
[2]   PROGNOSTIC VALUE OF RENAL BIOPSY IN ACUTE REJECTION OF KIDNEY-TRANSPLANTATION [J].
BANFI, G ;
IMBASCIATI, E ;
TARANTINO, A ;
PONTICELLI, C .
NEPHRON, 1981, 28 (05) :222-226
[3]  
BESCHORNER WE, 1985, TRANSPLANT P, V17, P618
[4]   IMMUNOPATHOLOGICAL PATTERNS IN LONG-TERM RENAL-ALLOGRAFTS [J].
BOHMAN, SO ;
WILCZEK, HE ;
REINHOLT, FP ;
VONWILLEBRAND, E ;
HAYRY, P .
TRANSPLANTATION, 1991, 51 (03) :610-613
[5]   CHARACTERISTICS OF EARLY ROUTINE RENAL-ALLOGRAFT BIOPSIES [J].
BURDICK, JF ;
BESCHORNER, WE ;
SMITH, WJ ;
MCGRAW, D ;
BENDER, WL ;
WILLIAMS, GM ;
SOLEZ, K .
TRANSPLANTATION, 1984, 38 (06) :679-684
[6]  
BURDICK JF, 1993, KIDNEY INT, V43, P1058
[7]   KIDNEY-TRANSPLANTS IN CYCLOSPORINE-TREATED SPRAGUE-DAWLEY RATS [J].
CHURCHILL, M ;
KLINE, R ;
SCHWARTZ, M ;
BIDANI, A ;
CHURCHILL, P .
TRANSPLANTATION, 1990, 49 (01) :8-13
[8]  
COLVIN RB, 1983, TRANSPL P, V15, P1166
[9]  
COLVVIN RB, 1988, DIAGNOSTIC IMMUNOPAT, P51
[10]  
CROKER BP, 1989, RENAL PATHOLOGY CLIN, P1518